首页 工具
登录
购物车

搜索结果

Search Results for " lipoprotein ldl "

27

抑制剂 & 化合物

1

天然产物

如果没找到您满意的产品或者您对产品有其他要求,可以联系我们专业顾问为您提供针对性的合理建议。     QQ咨询       网站留言咨询

提交您的定制咨询

点击图片重新获取验证码
Cat. No. Product Name Target Signaling Pathways
T2499 Torcetrapib

CP-529414,托彻普

CETP Metabolism
是胆固醇酯转移蛋白 (CETP) 选择性抑制剂。根据人血浆的抑制曲线,Torcetrapib (CP-529414) 对CETP 的最有效浓度为 37 nM。
T7832 Ibrolipim

NO-1886

LPL Receptor GPCR/G Protein
Ibrolipim (NO-1886) 是口服具有活力的脂蛋白脂肪酶 (LPL) 激活剂。它能够降低血浆甘油三酸酯,增加高密度脂蛋白胆固醇水平,具有肾保护和降血脂的作用。
T1771 Ro 48-8071 fumarate

Others Others
Ro 48-8071 fumarate 是一种氧化鲨烯环化酶抑制剂(IC50:6.5 nM)。
T20887 Atorvastatin Sodium

Lipitor

LDL; Aquaporin; HMG-CoA Reductase Membrane transporter/Ion channel; Metabolism
Atorvastatin Sodium (Lipitor) 是一种HMG-CoA 还原酶的竞争性抑制剂,增加肝细胞上低密度脂蛋白(LDL)受体的表达。Atorvastatin sodium 处理抑制水汽蛋白4来减轻缺血性脑水肿。
T76739 Bococizumab

RN316,PF-04950615

Others Others
Bococizumab(PF-04950615) 是一种针对PCSK9的人源化mAb,也是一种在肝脏中合成PCSK9的抑制剂,可降低低密度脂蛋白胆固醇 (LDL-C) 在血液中的含量。Bococizumab 可用于治疗高胆固醇血症。
T70504 6,8-Diprenyleriodictyol

6,8-Diprenyleriodictyol is an antioxidant, which inhibits Cu(2+)-mediated oxidation of human low density lipoprotein (LDL).
T11386 Gemcabene calcium

PD-72953 calcium

Others Others
Gemcabene calcium , a first-in-class lipid-lowering agent, lowers low-density lipoprotein cholesterol (LDL-C), decreases triglycerides, and raises high-density lipoprotein cholesterol (HDL-C) andexerting anti-inflammatory activity, lowers pro-inflammatory acute-phase protein, C-reactive protein (CRP).
T15561 Imanixil

HOE-402(free base)

Others Others
Imanixil is an inducer of the LDL receptor (LDLR) and it is also a potent cholesterol-lowering compound. It also inhibits very low density-lipoprotein (VLDL) production and consequently decreases atherosclerosis development.
T38908 MK-8262

MK-8262, an orally active and potent cholesteryl ester transfer protein (CETP) inhibitor (IC 50 = 53 nM, log D = 5.3), is a bistrifluoromethyl analogue that shows promise in research related to high-density lipoprotein (HDL) and low-density lipoprotein (LDL) with potential implications for coronary heart disease (CHD).
T73008 PCSK9-IN-13

PCSK9-IN-13 是一种有效的PCSK9抑制剂, 可通过与 PCSK9 结合作用来拮抗低密度脂蛋白(LDL) 受体结合,其IC50值为 537 nM。
T60646 PCSK9 modulator-3

PCSK9 modulator-3 (Compound 13) 是PCSK9的有效调节剂,EC50值为 2.46 nM,在高脂血症研究中具有潜力。PCSK9 是已证实的降低低密度脂蛋白胆固醇 (LDL-C) 的靶点。
T60541 PCSK9 modulator-2

PCSK9 modulator-2 (Compound 1) 是一种有效的PCSK9调节剂(EC50 = 202 nM), 具有用于高脂血症的研究潜力。PCSK9 是降低低密度脂蛋白胆固醇 (LDL-C) 的靶点。
T36171 KDdiA-PC

Oxidized low-density lipoprotein (oxLDL) particles contain low molecular weight species which are cytotoxic and pro-atherogenic. Many of these substances were recently isolated and purified from oxLDL, and identified as phosphatidylcholine species containing a fragmented, oxidized short-chain fatty acid remnant at the sn-2 position. KDdiA-PC is one of the most potent CD36 ligands among the oxLDL species. KDdiA-PC confers CD-36 scavenger receptor binding affinity to LDL at a frequency of only two...
T60764 PCSK9 modulator-4

PCSK9 modulator-4 (Compound 21) 是可以用于高血脂研究的,PCSK9的有效调节剂 (EC 50 = 0.15 nM)。PCSK9 是得到验证的一种降低低密度脂蛋白胆固醇 (LDL-C) 的靶标。
T77144 Recaticimab

Recaticimab (SHR-1209) 是一种针对 PCSK9 的人源化单克隆抗体。该药物通过结合 PCSK9 并促进其降解,增加肝细胞表面的低密度脂蛋白 (LDL) 受体数量,从而有效降低血浆 LDL 水平,实现降低血脂的效果。Recaticimab 对于治疗高胆固醇血症显示出潜在价值。
T68695 (R)-Bambuterol

Bambuterol is a prodrug of β2-agonist commonly used for the treatment of asthma and chronic obstructive pulmonary disease (COPD) with the advantage of once daily dosing and favorable side effect profile. Administration of a single-dose of R-bambuterol resulted in dose-dependent reductions in the levels of plasma LDL-C, high-density lipoprotein cholesterol (HDL-C), total cholesterol (TC), apolipoprotein B (ApoB) and apolipoprotein A1 (ApoA1) at Tmax. R-bambuterol can lower the plasma levels of LD...
T70660 Azalanstat HCl

Azalanstat HCl is an anti-obesity drug acting as a lanosterol 14α-demethylase inhibitor. Azalanstat HCl has been shown to inhibit cholesterol synthesis in HepG2 cells, human fibroblasts, hamster hepatocytes and hamster liver, by inhibiting the cytochrome P450 enzyme lanosterol 14 alpha-demethylase. When administered orally to hamsters fed regular chow, RS-21607 (50 mg/kg/day) lowered serum cholesterol in a dose-dependent manner (ED50 = 62 mg/kg) in a period of 1 week. It preferentially lowered l...
T70661 Azalanstat mesylate

Azalanstat mesylate is an anti-obesity drug acting as a lanosterol 14α-demethylase inhibitor. Azalanstat mesylate has been shown to inhibit cholesterol synthesis in HepG2 cells, human fibroblasts, hamster hepatocytes and hamster liver, by inhibiting the cytochrome P450 enzyme lanosterol 14 alpha-demethylase. When administered orally to hamsters fed regular chow, RS-21607 (50 mg/kg/day) lowered serum cholesterol in a dose-dependent manner (ED50 = 62 mg/kg) in a period of 1 week. It preferentially...
T75537 N-Acetyldopamine dimer-2

N-Acetyldopamine dimer-2(compound 2)是一种从蝉皮黄色粉末中分离出来的N-acetyldopamine二聚体,具有抗氧化和抗炎作用。它能抑制氧化低密度脂蛋白(LDL)的氧化、ROS的生成、NO的生成以及NF-κB的活性。
T79051 PCSK9-IN-15

PCSK9-IN-15(化合物5)是一种高效PCSK9抑制剂,亲和力强(KD<200 nM)。该化合物与胆固醇代谢相关,可调控低密度脂蛋白胆固醇(LDL-C)水平,适用于研究降低胆固醇及血脂异常。
T74577 Milpocitide

Milpocitide为针对低密度脂蛋白受体(human LDL receptor, LDLR)(293-333)的肽片段(EGF-like domain 1)的化合物。
T62380 20-HC-Me-Pyrrolidine

20-HC-Me-Pyrrolidine 是一种有效的 Aster 蛋白抑制剂,对 Aster-A、Aster-B 和 Aster-C 具有抑制作用, IC50 分别为 0.11 μM、0.06 μM 和 0.71 μM。20-HC-Me-Pyrrolidine 阻止 Aster 蛋白结合和转移胆固醇,抑制低密度脂蛋白 (LDL) 胆固醇向内质网 (ER) 的移动。
T62598 Pitavastatin sodium

Pitavastatin (NK-104) sodium 是一种有效的羟甲基戊二酰-CoA(HMG-CoA) 还原酶抑制剂,也是一种高效的肝细胞低密度脂蛋白胆固醇 (LDL-C) 受体诱导剂。Pitavastatin sodium 在 HepG2 细胞中,能够抑制乙酸合成胆固醇 (IC50: 5.8 nM) 。Pitavastatin sodium 表现出抗动脉粥样硬化、抗哮喘、抗骨关节炎、神经保护、抗肿瘤、肝保护和肾保护作用。
T62052 AMPK activator 6

AMPK activator 6 (Compound GC) 可降低 HepG2 和 3T3-L1 细胞中的脂质含量并激活AMPK 通路。AMPK activator 6 对血清中甘油三酯 (TG)、总胆固醇 (TC)、低密度脂蛋白-C (LDL-C) 和其他生化指标的增加有显著的抑制作用。AMPK activator 6 在非酒精性脂肪肝(NAFLD)和代谢综合征中有研究价值。
T7072 Pitavastatin

Pitavastatin (NK-104) 是有效的羟甲基戊二酰-CoA(HMG-CoA)还原酶抑制剂。Pitavastatin 抑制乙酸合成胆固醇,在 HepG2 细胞中的IC50为 5.8 nM。Pitavastatin 是一种高效的肝细胞低密度脂蛋白胆固醇 (LDL-C) 受体诱导剂。Pitavastatin 具有抗动脉粥样硬化、抗哮喘、抗骨关节炎、抗肿瘤、神经保护、肝保护和肾保护等作用。
T35813 CAY10592

Peroxisome proliferator-activated receptors (PPARs) α, δ, γ are ligand-activated nuclear transcription factors involved in the regulation of energy homeostasis as well as insulin sensitivity and glucose metabolism. Pharmacologies of PPARδ receptor agonists, though relatively obscure, have recently been reported to elevate high-density lipoprotein (HDL) cholesterol and lower plasma triglyceride (TG) levels in obese insulin resistant rhesus monkeys. CAY10592 is a full PPARδ agonist (EC50 = 30 nM) ...
T77123 Orticumab

Orticumab (MLDL1278A) 为靶向氧化或丙二醛修饰的低密度脂蛋白(LDL)抗体,特异性抑制氧化低密度脂蛋白(oxLDL)。通过参与调节针对oxLDL的自身免疫反应,Orticumab能够改善动物模型中的动脉粥样硬化现象,并在银屑病改善研究中发挥作用。

化合物

Torcetrapib
Cat.No: T2499
Synonym: CP-529414,托彻普
Target: CETP
Ibrolipim
Cat.No: T7832
Synonym: NO-1886
Target: LPL Receptor
Ro 48-8071 fumarate
Cat.No: T1771
Synonym:
Target: Others
Atorvastatin Sodium
Cat.No: T20887
Synonym: Lipitor
Target: LDL, Aquaporin, HMG-CoA Reductase
Bococizumab
Cat.No: T76739
Synonym: RN316,PF-04950615
Target: Others
6,8-Diprenyleriodictyol
Cat.No: T70504
Synonym:
Target:
Gemcabene calcium
Cat.No: T11386
Synonym: PD-72953 calcium
Target: Others
Imanixil
Cat.No: T15561
Synonym: HOE-402(free base)
Target: Others
MK-8262
Cat.No: T38908
Synonym:
Target:
PCSK9-IN-13
Cat.No: T73008
Synonym:
Target:
PCSK9 modulator-3
Cat.No: T60646
Synonym:
Target:
PCSK9 modulator-2
Cat.No: T60541
Synonym:
Target:
KDdiA-PC
Cat.No: T36171
Synonym:
Target:
PCSK9 modulator-4
Cat.No: T60764
Synonym:
Target:
Recaticimab
Cat.No: T77144
Synonym:
Target:
(R)-Bambuterol
Cat.No: T68695
Synonym:
Target:
Azalanstat HCl
Cat.No: T70660
Synonym:
Target:
Azalanstat mesylate
Cat.No: T70661
Synonym:
Target:
N-Acetyldopamine dimer-2
Cat.No: T75537
Synonym:
Target:
PCSK9-IN-15
Cat.No: T79051
Synonym:
Target:
Milpocitide
Cat.No: T74577
Synonym:
Target:
20-HC-Me-Pyrrolidine
Cat.No: T62380
Synonym:
Target:
Pitavastatin sodium
Cat.No: T62598
Synonym:
Target:
AMPK activator 6
Cat.No: T62052
Synonym:
Target:
Pitavastatin
Cat.No: T7072
Synonym:
Target:
CAY10592
Cat.No: T35813
Synonym:
Target:
Orticumab
Cat.No: T77123
Synonym:
Target:
Cat. No. Product Name Target Signaling Pathways
TN5057 Stachybotramide

LDL Metabolism
Stachybotramide preferentially stimulate the plasma cholesteryl ester transfer protein (CETP)-mediated transfer of cholesteryl esters (CE) from high density lipoprotein (HDL) to both very low density lipoprotein (VLDL) and low density lipoprotein (LDL).

天然产物

Stachybotramide
Cat.No: TN5057
Synonym:
Target: LDL
TargetMol Loading
联系我们
400-820-0310

上海市静安区江场三路238号8楼